MX351220B - Una variante nueva del factor viii antihemofilico que tiene actividad especifica incrementada. - Google Patents
Una variante nueva del factor viii antihemofilico que tiene actividad especifica incrementada.Info
- Publication number
- MX351220B MX351220B MX2016015430A MX2016015430A MX351220B MX 351220 B MX351220 B MX 351220B MX 2016015430 A MX2016015430 A MX 2016015430A MX 2016015430 A MX2016015430 A MX 2016015430A MX 351220 B MX351220 B MX 351220B
- Authority
- MX
- Mexico
- Prior art keywords
- factor viii
- specific activity
- increased specific
- new variant
- antihemophilic factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
La presente invención se refiere a un polinucleótido que codifica una variante de factor VIII (FVIII) porcino con dominio B completa o parcialmente eliminando, la variante FVIII comprende una secuencia que es al menos 90% idéntica a la SEQ ID NO: 1; y desprovista de una secuencia de aminoácidos correspondiente a los aminoácidos 716 a 742 del factor VIII porcino como se representa en la Figura 2 o los aminoácidos 714 a 740 de la SEQ ID NO; 7.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41043710P | 2010-11-05 | 2010-11-05 | |
PCT/US2011/059297 WO2012061689A2 (en) | 2010-11-05 | 2011-11-04 | A new variant of antihemophilic factor viii having increased specific activity |
Publications (1)
Publication Number | Publication Date |
---|---|
MX351220B true MX351220B (es) | 2017-10-05 |
Family
ID=46025129
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016015430A MX351220B (es) | 2010-11-05 | 2011-11-04 | Una variante nueva del factor viii antihemofilico que tiene actividad especifica incrementada. |
MX2013005047A MX347503B (es) | 2010-11-05 | 2011-11-04 | Una variante nueva del factor viii antihemofílico que tiene actividad específica incrementada. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013005047A MX347503B (es) | 2010-11-05 | 2011-11-04 | Una variante nueva del factor viii antihemofílico que tiene actividad específica incrementada. |
Country Status (18)
Country | Link |
---|---|
US (2) | US9150637B2 (es) |
EP (1) | EP2635297B1 (es) |
JP (1) | JP5922141B2 (es) |
KR (1) | KR101948337B1 (es) |
CN (1) | CN103298483B (es) |
AU (1) | AU2011323236B2 (es) |
BR (1) | BR112013011041B1 (es) |
CA (1) | CA2816575C (es) |
CO (1) | CO6720990A2 (es) |
DK (1) | DK2635297T3 (es) |
EA (1) | EA035447B1 (es) |
ES (1) | ES2721478T3 (es) |
IL (1) | IL226158B (es) |
MX (2) | MX351220B (es) |
MY (1) | MY165089A (es) |
SG (2) | SG10201509149VA (es) |
WO (1) | WO2012061689A2 (es) |
ZA (1) | ZA201303816B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10654910B2 (en) | 2015-01-30 | 2020-05-19 | Emory University | Factor VIII proteins having ancestral sequences, expression vectors, and uses related thereto |
CN109689683A (zh) | 2016-06-24 | 2019-04-26 | 财团法人牧岩生命科学研究所 | 重组单链fvⅲ及其化学缀合物 |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4348384A (en) | 1980-10-17 | 1982-09-07 | Dainippon Pharmaceutical Co., Ltd. | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
EP0182448A3 (en) | 1984-08-24 | 1987-10-28 | Genetics Institute, Inc. | Production of factor viii and related products |
CA1341174C (en) | 1985-04-12 | 2001-01-30 | John J. Toole Jr. | Procoagulant proteins derived from factor viii: c |
JPS6281327A (ja) | 1985-10-04 | 1987-04-14 | Green Cross Corp:The | 人トロンビン製剤の加熱処理方法 |
JPH0387173A (ja) | 1987-09-10 | 1991-04-11 | Teijin Ltd | ヒト活性化天然型ファクター8cの製造方法及びそれに用いる形質転換体 |
JPS6485927A (en) | 1987-09-29 | 1989-03-30 | Green Cross Corp | Hepatitis b vaccine |
US5605884A (en) | 1987-10-29 | 1997-02-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Factor VIII formulations in high ionic strength media |
JPH0626980Y2 (ja) | 1987-11-26 | 1994-07-20 | ソニー株式会社 | 誤消去防止機構 |
WO1989009784A1 (en) | 1988-04-08 | 1989-10-19 | Commonwealth Serum Laboratories Commission | Production of heat-stable factor viii concentrate |
DK162233C (da) | 1989-11-09 | 1992-03-16 | Novo Nordisk As | Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii |
US5384132A (en) | 1990-03-20 | 1995-01-24 | Akzo N.V. | Stabilized gonadotropin containing preparations |
IE64738B1 (en) | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
DE4111393A1 (de) | 1991-04-09 | 1992-10-15 | Behringwerke Ag | Stabilisierte faktor viii-praeparationen |
US6180371B1 (en) | 1996-06-26 | 2001-01-30 | Emory University | Modified factor VIII |
US5364771A (en) | 1992-04-07 | 1994-11-15 | Emory University | Hybrid human/porcine factor VIII |
US6376463B1 (en) | 1992-04-07 | 2002-04-23 | Emory University | Modified factor VIII |
US5663060A (en) | 1992-04-07 | 1997-09-02 | Emory University | Hybrid human/animal factor VIII |
US5859204A (en) | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
US5744446A (en) | 1992-04-07 | 1998-04-28 | Emory University | Hybrid human/animal factor VIII |
US5888974A (en) | 1992-04-07 | 1999-03-30 | Emory University | Hybrid human/animal factor VIII |
ATE198277T1 (de) | 1992-10-02 | 2001-01-15 | Genetics Inst | Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator |
US5563045A (en) * | 1992-11-13 | 1996-10-08 | Genetics Institute, Inc. | Chimeric procoagulant proteins |
SE9301581D0 (sv) | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
CA2162497A1 (en) | 1993-06-10 | 1994-12-22 | Sheila Connelly | Adenoviral vectors for treatment of hemophilia |
SE504074C2 (sv) | 1993-07-05 | 1996-11-04 | Pharmacia Ab | Proteinberedning för subkutan, intramuskulär eller intradermal administrering |
IL113010A0 (en) | 1994-03-31 | 1995-10-31 | Pharmacia Ab | Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration |
ZA955642B (en) | 1994-07-07 | 1997-05-06 | Ortho Pharma Corp | Lyophilized imaging agent formulation |
JPH0899999A (ja) | 1994-09-30 | 1996-04-16 | Chemo Sero Therapeut Res Inst | α1プロテアーゼインヒビターの製造方法 |
US6818439B1 (en) | 1994-12-30 | 2004-11-16 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders |
WO1997003191A1 (en) | 1995-07-11 | 1997-01-30 | Chiron Corporation | Novel factor viii:c polypeptide analogs comprising factor v domains or subdomains |
AU6455896A (en) | 1995-07-11 | 1997-02-10 | Chiron Corporation | Novel factor viii:c polypeptide analogs with altered metal-binding properties |
PT1754718E (pt) * | 1996-04-24 | 2011-07-13 | Univ Michigan | Factor viii resistente à inactivação |
US7560107B2 (en) | 1996-06-26 | 2009-07-14 | Emory University | Modified factor VIII |
US6458563B1 (en) | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
US5763401A (en) | 1996-07-12 | 1998-06-09 | Bayer Corporation | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
JP2002517180A (ja) | 1997-12-05 | 2002-06-18 | ジ・イミユーン・リスポンス・コーポレーシヨン | 増大された発現を示す新規ベクターおよび遺伝子 |
US6200560B1 (en) | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
US6759216B1 (en) | 1998-11-06 | 2004-07-06 | Emory University | Glycosylated, low antigenicity low immunogenicity factor VIII |
PT2130554E (pt) | 1999-02-22 | 2012-11-19 | Univ Connecticut | Formulações de factor viii isentas de albumina |
ES2252028T3 (es) | 1999-07-13 | 2006-05-16 | Biovitrum Ab | Composiciones estables del factor viii. |
US6333192B1 (en) | 1999-08-09 | 2001-12-25 | North Carolina State University | Method of producing an undifferentiated avian cell culture using avian primordial germ cells |
US6586574B1 (en) | 1999-08-17 | 2003-07-01 | Nn A/S | Stabilization of freeze-dried cake |
US7576182B1 (en) | 1999-08-31 | 2009-08-18 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
PL206105B1 (pl) | 2000-09-19 | 2010-07-30 | Emory Universityemory University | Zmodyfikowany ludzki czynnik VIII oraz sposób modyfikacji ludzkiego czynnika VIII ze zmniejszeniem reaktywności na przeciwciało hamujące i zachowaniem aktywności prokoagulacyjnej |
AU2002337901B2 (en) * | 2001-10-05 | 2008-01-17 | Expression Therapeutics Llc | Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
EP1456235A4 (en) | 2001-11-30 | 2005-08-17 | Univ Emory | VARIANTS OF DOMAIN C2 OF FACTOR VIII |
GB0207092D0 (en) | 2002-03-26 | 2002-05-08 | Sod Conseils Rech Applic | Stable pharmaceutical composition containing factor VIII |
US7041635B2 (en) * | 2003-01-28 | 2006-05-09 | In2Gen Co., Ltd. | Factor VIII polypeptide |
WO2005046583A2 (en) | 2003-10-30 | 2005-05-26 | Emory University | Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
US7939634B2 (en) | 2004-01-27 | 2011-05-10 | Compugen Ltd. | Polynucleotides encoding polypeptides and methods using same |
PL1750733T3 (pl) | 2004-05-03 | 2014-05-30 | Univ Emory | Sposób podawania świńskiego czynnika krzepnięcia VIII pozbawionego domeny B |
RU2423380C2 (ru) | 2004-11-12 | 2011-07-10 | БАЙЕР ХЕЛСКЕА ЛЛСи | Сайт-направленная модификация fviii |
KR101542752B1 (ko) | 2006-12-22 | 2015-08-10 | 체에스엘 베링 게엠베하 | 연장된 생체내 반감기를 갖는 변형된 응고 인자 |
WO2009075772A1 (en) * | 2007-12-06 | 2009-06-18 | Wyeth | Crystal structure of human factor viii and uses thereof |
-
2011
- 2011-11-04 AU AU2011323236A patent/AU2011323236B2/en active Active
- 2011-11-04 DK DK11838863.6T patent/DK2635297T3/da active
- 2011-11-04 EA EA201390654A patent/EA035447B1/ru not_active IP Right Cessation
- 2011-11-04 ES ES11838863T patent/ES2721478T3/es active Active
- 2011-11-04 CA CA2816575A patent/CA2816575C/en active Active
- 2011-11-04 MX MX2016015430A patent/MX351220B/es unknown
- 2011-11-04 EP EP11838863.6A patent/EP2635297B1/en active Active
- 2011-11-04 US US13/883,244 patent/US9150637B2/en active Active
- 2011-11-04 WO PCT/US2011/059297 patent/WO2012061689A2/en active Application Filing
- 2011-11-04 CN CN201180063748.0A patent/CN103298483B/zh active Active
- 2011-11-04 SG SG10201509149VA patent/SG10201509149VA/en unknown
- 2011-11-04 SG SG2013034137A patent/SG190136A1/en unknown
- 2011-11-04 KR KR1020137014351A patent/KR101948337B1/ko active IP Right Grant
- 2011-11-04 BR BR112013011041-4A patent/BR112013011041B1/pt active IP Right Grant
- 2011-11-04 MY MYPI2013001627A patent/MY165089A/en unknown
- 2011-11-04 JP JP2013537859A patent/JP5922141B2/ja not_active Expired - Fee Related
- 2011-11-04 MX MX2013005047A patent/MX347503B/es active IP Right Grant
-
2013
- 2013-05-05 IL IL226158A patent/IL226158B/en active IP Right Grant
- 2013-05-24 ZA ZA2013/03816A patent/ZA201303816B/en unknown
- 2013-06-05 CO CO13136450A patent/CO6720990A2/es unknown
-
2015
- 2015-08-25 US US14/834,769 patent/US10053500B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019013123A (es) | Dosificacion oral de compuestos peptido similar al glaucon-1 (glp-1). | |
CA144362S (en) | Combined dishwashing and scrubbing tool | |
MX2013001540A (es) | Composiciones que comprende un polipeptido que tiene actividad de incremento celulolititico y un compuesto de quinona, y uso de las mismas. | |
MX356525B (es) | Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia. | |
ZA201206697B (en) | Inverted dome to supply dose | |
PH12014502537A1 (en) | Therapeutic uses of fibroblast growth factor 21 proteins | |
IN2014DN09085A (es) | ||
IN2014DN06104A (es) | ||
BR112014014896A2 (pt) | nova combinação | |
PH12015500585A1 (en) | Modified hyaluronic acid derivatives and use thereof | |
MX2015007727A (es) | 6-cloro-3-(fenil-d5)inden-1-ona y su uso. | |
MX2013002539A (es) | Sobrenadante condicionado por leucocitos activados y usos para la cicatrizacion de heridas. | |
CY1117053T1 (el) | Συνθεση μελιου με l-αλανυλ-l-γλουταμινη | |
MX2013005047A (es) | Una variante nueva del factor viii antihemofilico que tiene actividad especifica incrementada. | |
UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
MX354501B (es) | Ingrediente perfumante de la familia galbano. | |
FR2969615B1 (fr) | Nouveau complexes carbeniques de platine et leur utilisation comme medicaments | |
IN2015DN02647A (es) | ||
MX2013002485A (es) | Fenilacetamidas y fenilpropanamidas sustituidas y su uso. | |
UA94339C2 (ru) | применение корвитина в качестве средства фригопротекторного действия | |
AU338253S (en) | Retail Unloader | |
AU336535S (en) | Medical dressing | |
AU336536S (en) | Medical dressing | |
AU2010904081A0 (en) | Delivery of Fabric Care Products | |
UA72478U (ru) | Применение полентара как средства фригопротекторного действия |